PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia.\', \'La Trobe University - La Trobe Institute for Molecular Science (LIMS), Melbourne, Australia.\', \'Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia.\', \'QIMR Berghofer Medical Research Institute - QIMR Berghofer Centre for Immunotherapy and Vaccine Development Brisbane, Australia.\', \'Department of Endocrinology, Mater Health, Brisbane, Australia.\', \'Mater Research Institute, The University of Queensland, Brisbane, Australia.\', \'School of Biomedical Sciences, The University of Queensland, St Lucia, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/febs.16105
?:doi
?:hasPublicationType
?:journal
  • The FEBS journal
is ?:pmid of
?:pmid
?:pmid
  • 34216102
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • The role of T-cell immunity in COVID-19 severity amongst people living with type II diabetes.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all